AnGes, Inc.
AnGes, Inc. (AMGXF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AMGXF · as of Jun 8, 2026
Key Statistics
Explore AnGes, Inc. Data
amgxf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
amgxf competitorsAMGXF
AAPGV
ADOCY
EKDHF
EPRXF
FPHAFStock Performance
Full HistoryAbout AnGes, Inc.
AnGes, Inc. a biopharmaceutical company, engages in the research and development of gene-based medical products. Its lead product is Hepatocyte Growth Factor (HGF) Plasmid, a gene therapy for the tre…
what is anges, inc. · amgxf stock overview · anges, inc. company profile · who is anges, inc. ceo · amgxf OTC · anges, inc. headquarters · anges, inc. business segments
About Stock Overview & Key Data
AnGes, Inc. (AMGXF) is a Healthcare company in the Biotechnology industry, listed on OTC since Jul 3, 2017. As of the latest trading session, AMGXF stock price is $0.36, with a market capitalization of $142.5M. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
In fiscal year 2025, AnGes, Inc. reported revenue of $874.9M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, AnGes, Inc. (AMGXF) stock price is $0.36. The stock is traded on OTC under the ticker symbol AMGXF. The 52-week range is $0.34 – $0.36.